| Not Yet Recruiting | Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multip Multiple Myeloma | Phase 3 | 2026-05-01 |
| Recruiting | Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer Extensive Stage Lung Small Cell Cancer | Phase 2 | 2026-03-30 |
| Recruiting | Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation, Stage III Lung Cancer | — | 2024-09-17 |
| Completed | DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma Mesothelioma, Pleural Mesothelioma, Malignant Pleural Mesothelioma | Phase 3 | 2021-02-18 |
| Completed | Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years o Mantle Cell Lymphoma | Phase 2 | 2020-01-13 |
| Active Not Recruiting | Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 2 | 2019-12-06 |
| Completed | Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Bladder Cancer | Phase 1 | 2019-03-22 |
| Completed | A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Mantle-Cell Lymphoma | Phase 1 / Phase 2 | 2018-08-13 |
| Completed | Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Ther Follicular Lymphoma, Non-Hodgkin's Lymphoma Follicular, Non-Hodgkin's Lymphoma, Adult High Grade | Phase 2 | 2017-12-27 |
| Completed | Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma Mesothelioma, Pleural Mesothelioma | Phase 2 | 2017-06-13 |
| Terminated | Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung Squamous Cell Carcinoma of the Lung | Phase 1 / Phase 2 | 2016-04-10 |
| Completed | Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma Cholangiocarcinoma | Phase 2 | 2014-12-09 |
| Terminated | Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's L Indolent Non-Hodgkin's Lymphoma | Phase 2 | 2013-12-01 |
| Completed | Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to A Metastatic Breast Cancer | Phase 2 | 2013-05-31 |
| Terminated | NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Car Renal Cell Carcinoma | Phase 2 | 2012-07-01 |
| Terminated | Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2012-07-01 |
| Terminated | Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfun Multiple Myeloma, Plasma Cell Neoplasm | Phase 1 / Phase 2 | 2009-01-21 |
| Completed | Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer Lung Cancer, Non Small Cell Lung Cancer | Phase 2 | 2008-04-01 |